PlainRecalls
LowClass IIITerminated

FDA Drug recall · Reported February 20, 2019

Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86

Defective Container; complaints of leakage.

Recall #
D-0492-2019
Affected scope
53,358 bottles
Initiated
January 11, 2019
Verify with FDA Drug →
View my saved recalls

Oxalis Labs recalled Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Ma… - a low-severity action.

Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Ma… was recalled by Oxalis Labs in February 20, 2019. Reason: Defective Container; complaints of leakage.. Check the official notice for the remedy. Verify recall #D-0492-2019 with the FDA Drug before acting.

The recall

Oxalis Labs issued this low-severity FDA Drug recall-Defective Container; complaints of leakage..

Low
severity level
Class III
classification
February 20, 2019
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0492-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0492-2019) was formally reported on February 20, 2019, with the manufacturer initiating the action on January 11, 2019. It is classified under Low severity (Class III), with a current status of Terminated. Oxalis Labs is listed as the recalling firm, operating out of Theda, N/A. Federal records list the affected scope as 53,358 bottles.

The documented reason for this recall is: Defective Container; complaints of leakage. Distribution data in the federal record shows the product reached: Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,772 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 187
Severity1902064468High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

53,358 bottles

Related Recalls

6

0 from same agency

Product description

Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86

Reason for recall

Defective Container; complaints of leakage.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number D-0492-2019
Date reported February 20, 2019
Date initiated January 11, 2019
Recalling firm Oxalis Labs
Firm location Theda, N/A
Affected scope 53,358 bottles
Distribution Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0492-2019) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86. Recalled by Oxalis Labs. Units affected: 53,358 bottles.
Why was this product recalled?
Defective Container; complaints of leakage.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 20, 2019. Severity: Low. Recall number: D-0492-2019.
Where was the recalled product distributed?
Distribution: Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States..
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0492-2019) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Showing 5 of 4006 other recalls in this category.

Compare this recall with A2batt Recalls EEMB Lithium Coin Battery Chargers Due to Ri… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 20, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.